Serum alphaJadrenomodulating activity in arterial hypertension
In experiments with longitudinal stripes of cow renal artery, serum taken from healthy people and patients with Stage II arterial hypertension (AH), in titrations 1:100, 1:500, 1:1000, and 1:10000, did not influence tonotropic, alpha-drenoreceptor (AR) activating effect of adrenaline (10–6 g/ml). In...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2008-02-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1530 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | In experiments with longitudinal stripes of cow renal artery, serum taken from healthy people and patients with Stage II arterial hypertension (AH), in titrations 1:100, 1:500, 1:1000, and 1:10000, did not influence tonotropic, alpha-drenoreceptor (AR) activating effect of adrenaline (10–6 g/ml). In titration 1:50, this effect was enhanced, due to serum alpha-adrenosensitizing activity. In Stage III AH, female serum did not affect tonotropic effect of adrenaline, and male serum reduced it in titrations 1:50, 1:100, and 1:1000, due to alpha-adrenoblocking activity. Therefore, 1) serum of cormotensive people and patients with Stage II AH could contain endogenous sensitizer of alpha-AR (ESAAR), and in Stage III AH its level might be reduced; 2) serum of males with Stage III AH could contain endogenous blocker of alpha?AR (EBAAR). The nature of ASAAR and EBAAR and their role in AH pathogenesis is discussed. |
|---|---|
| ISSN: | 1560-4071 2618-7620 |